groups. Type-2 TTE, accompanied by persistent mullerian duct syndrome, constitutes
approximately 20% of the patients. Surgical treatment should be planned after careful
physical examination, ultrasonography, and genetic/endocrinologic evaluation.
Herniorrhaphy, orchiopexy with testicular biopsy, and excision of the mullerian structures are
the most appropriate surgical approaches in cases of